Information  X 
Enter a valid email address

Redcentric PLC (RCN)

  Print      Mail a friend

Wednesday 09 October, 2019

Redcentric PLC

Trading Update

RNS Number : 1691P
Redcentric PLC
09 October 2019
 

Redcentric plc

("Redcentric" or the "Company")

 

Trading update

 

Redcentric plc (AIM: RCN), a leading UK IT managed services provider, today announces a trading update for the six months ended 30 September 2019.

 

Trading for the half year has been in line with the Board's expectations and the Company remains focussed on its new and existing customers in both the public and private sectors. The Company's net debt1 at 30 September 2019 was £16.5m (31 March 2019: £17.6m; 30 September 2018 £22.6m), despite dividend payments of £1.5m and an acceleration of network and infrastructure capital expenditure in the period. The Company has also commenced a share buyback programme as announced on 17 September.

The Company intends to announce its results for the half year ended 30 September 2019 on Thursday 28 November 2019.

1 excluding the impact of IFRS 16

Enquiries:

Redcentric plc

Peter Brotherton, Chief Executive Officer                                                                            Via Tulchan

Dean Barber, Chief Financial Officer

Tulchan

James Macey White, Matt Low                                                                                  +44 (0)20 7353 4200

Numis Securities Limited - Nomad and Joint Broker                                            +44 (0)20 7260 1000

Simon Willis / Oliver Hardy

finnCap Limited - Joint Broker                                                                                   +44 (0)20 7220 0500

Stuart Andrews / Rhys Williams

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
TSTUGGRCUUPBGGR

a d v e r t i s e m e n t